课题基金 / 基金详情

VEGF in situ macular edema & uveitis

VEGF in situ macular edema & uveitis
VEGF原位黄斑水肿
批准号:
6227960
负责人:
ROBERT B. NUSSENBLATT
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

ROBERT B. NUSSENBLATT的其他基金

相似基金

相关文献

中文摘要
翻译
眼内和全身血管生成因子血管内皮生长因子(VEGF)水平升高与眼部新血管生长有关,如糖尿病视网膜病变。最近使用免疫病理学技术的研究表明,VEGF在实验诱导的葡萄膜炎和葡萄膜炎眼睛中都是上调的,没有新血管形成的证据。这项初步研究将评估伴有和不伴有囊样黄斑水肿的葡萄膜患者血液中VEGF的水平。这一水平也将在接受眼科手术的患者的眼液中测定。这些水平将与年龄和性别匹配的对照组进行比较。葡萄膜炎,囊样黄斑水肿,vegf,血管内皮生长因子
英文摘要
Increased intraocular and systemic levels of the angiogenic factor vascular endothelial growth factor (VEGF) is associated with new vessel growth in the eye, such as diabetic retinopathy. Recent work using immunopathologic techniques have shown that VEGF is upregulated in both experimentally induced uveitis and in uveitis eyes as well, with no evidence of neovascularization. This pilot study will evaluate the level of VEGF in the blood of uveitic patients with and without cystoid macular edema. This level will be determined also in the ocular fluid of those patietns undergoing ocular surgery. These levels will be compared with age and sex matched controls. - uveitis, cystoid macular edema, vegf,vascular endothelial growth factor
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Anti Tac Antibody Treatment in Behcet's Disease
  • 批准号:
    6227961
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    ROBERT B. NUSSENBLATT
  • 依托单位:
Biology/Immunology Of Corneal Epithelial Stem Cells
  • 批准号:
    6507406
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    ROBERT B. NUSSENBLATT
  • 依托单位:
Nucleotide Polymorphisms In Primary Intraocular Lymphoma
  • 批准号:
    6507404
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    ROBERT B. NUSSENBLATT
  • 依托单位:
Vegf (in Situ Macular Edema & Uveitis
  • 批准号:
    6507390
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    ROBERT B. NUSSENBLATT
  • 依托单位:
海外基金